Skip to content
Screener

Septerna, Inc. SEPN Investing Cash Flow

Investing Cash Flow at other companies

Amgen logo
AmgenAMGN
-$569M-46.3%
Tectonic Therapeutics logo
Tectonic TherapeuticsTECX
-$19K+29.6%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$50.69M+272%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$25.6M+13.3%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$123.83M-585%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$35.35M-372%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.78B+240%
Enterprise value$1.73B+383%
P/S24.7×-696×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216759
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Purchases of property and equipment(832)(382)
Purchases of marketable securities(105,230)(49,715)
Maturities of marketable securities82,24545,223
Net cash used in investing activities(23,817)(4,874)
Cash flows from financing activities:
Proceeds from exercise of stock options33366
Net cash provided by financing activities33366
Net decrease in cash, cash equivalents and restricted cash(49,117)(28,151)

Item 1. Condensed Financial Statements.

FAQ

What is Septerna, Inc.'s investing cash flow?
Septerna, Inc. (SEPN) reported investing cash flow of -$23.82M in Q1 2026.
How has Septerna, Inc.'s investing cash flow changed year-over-year?
Septerna, Inc.'s investing cash flow decreased by 388.7% year-over-year, from -$4.87M to -$23.82M.
What is the long-term trend for Septerna, Inc.'s investing cash flow?
Over 2 years (2023 to 2025), Septerna, Inc.'s investing cash flow has grown at a 222.0% compound annual growth rate (CAGR), from $22.12M to -$229.35M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Septerna, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude